Back

Implantable devices in chronic Chagas cardiomyopathy: outcomes and a delayed response to CRT in a real-world cohort

29 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Cardiac implantable electronic devices therapy: from implant strategy to long-term management Implantable Cardioverter-Defibrillator (ICD) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Carlos Calderon Franco

University Hospital San Ignacio, Bogota (Colombia)

6 More presentations in this session

Presentation thumbnail
Ultrasound-guided combined PECS II and parasternal intercostal nerve block versus conventional local anesthesia for cardiac implantable electronic cevice emplantation: a prospective controlled Study
Doctor C. Korucu (Sanliurfa, TR)
Presentation thumbnail
Age and triggers of inappropriate implantable cardioverter-defibrillator therapy in primary prevention patients
Associate Professor A. Barsheshet (Petah Tikva, IL)
Abstract Slides Video
Presentation thumbnail
Early real-world outcomes of the 2023 refined dutch guidelines for non-ischemic cardiomyopathy mandating CRT-P treatment
Ms L. Broers (Nijmegen, NL)
Abstract Slides Video
Presentation thumbnail
Implantable cardioverter defibrillators in type 1 diabetes regarding indications, complications and prognosis
Doctor T. Wodaje (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Impaired sinus response during ventricular arrhythmia predicts adverse outcomes in implantable cardioverter-defibrillator recipients
Doctor M. Blondeel (Leuven, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac implantable electronic devices therapy: from implant strategy to long-term management

The Event

Event poster

ESC Congress 2026

29 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac resynchronization therapy in heart failure: clinical profile and follow-up of patients at a brazilian tertiary center
11 May 2024
thumbnail
Congress Presentation
Eighteen-year prognostic outcomes of acute heart failure resulting from orally transmitted Chagas disease
28 August 2026
thumbnail
Congress Presentation
Real-world implantable cardioverter-defibrillator outcomes in a north-african tertiary centre: baseline profile, arrhythmic therapies, device-related events and early outcomes
30 August 2026
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator therapy compared to amiodarone in Chagas cardiomyopathy: a systematic review and meta-analysis
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources